Kevin Kemp

2.7k total citations
70 papers, 2.1k citations indexed

About

Kevin Kemp is a scholar working on Molecular Biology, Genetics and Cellular and Molecular Neuroscience. According to data from OpenAlex, Kevin Kemp has authored 70 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Molecular Biology, 20 papers in Genetics and 17 papers in Cellular and Molecular Neuroscience. Recurrent topics in Kevin Kemp's work include Mesenchymal stem cell research (19 papers), Neurogenesis and neuroplasticity mechanisms (13 papers) and Genetic Neurodegenerative Diseases (9 papers). Kevin Kemp is often cited by papers focused on Mesenchymal stem cell research (19 papers), Neurogenesis and neuroplasticity mechanisms (13 papers) and Genetic Neurodegenerative Diseases (9 papers). Kevin Kemp collaborates with scholars based in United Kingdom, United States and Denmark. Kevin Kemp's co-authors include Alastair Wilkins, Neil Scolding, Kelly Hares, Elizabeth Mallam, Claire M Rice, Mark Ginty, Elizabeth Gray, Jill Hows, Craig Donaldson and Juliana Redondo and has published in prestigious journals such as The Lancet, Journal of Biological Chemistry and Nature Communications.

In The Last Decade

Kevin Kemp

68 papers receiving 2.0k citations

Peers

Kevin Kemp
Comparison fields: 5 of 128
  • Molecular Biology 807
  • Genetics 668
  • Cellular and Molecular Neuroscience 372
  • Developmental Neuroscience 305
  • Pathology and Forensic Medicine 253
Fernando Carceller Spain
Yongchao Ma China
Elisabet Lindqvist Sweden
Xuelian He China
Suh Young Jeong United States
Astrid Jeibmann Germany
Naoya Yamamoto Japan
Pablo Martı́n-Vasallo Spain
Ou Jin China
Fernando Carceller Spain View profile →
Citations per field, relative to Kevin Kemp
Kevin Kemp · 1×
Citations per year, relative to Kevin Kemp
Kevin Kemp · 1×

Countries citing papers authored by Kevin Kemp

Since Specialization
Citations

This map shows the geographic impact of Kevin Kemp's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kevin Kemp with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kevin Kemp more than expected).

Fields of papers citing papers by Kevin Kemp

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kevin Kemp. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kevin Kemp. The network helps show where Kevin Kemp may publish in the future.

Co-authorship network of co-authors of Kevin Kemp

This figure shows the co-authorship network connecting the top 25 collaborators of Kevin Kemp. A scholar is included among the top collaborators of Kevin Kemp based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kevin Kemp. Kevin Kemp is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
# Title Journal Authors Indexed citations
1 An open-label pilot study of recombinant granulocyte-colony stimulating factor in Friedreich’s ataxia Nature Communications Kevin Kemp, Kelly Hares et al. 2
2 KIF5A and the contribution of susceptibility genotypes as a predictive biomarker for multiple sclerosis Journal of Neurology Kelly Hares, Kevin Kemp et al. 7
3 Evaluation of the quality of RNA extracted from archival FFPE glioblastoma and epilepsy surgical samples for gene expression assays Journal of Clinical Pathology Harry R. Haynes, Kelly Hares et al. 13
4 Aberrant cerebellar Purkinje cell function repaired in vivo by fusion with infiltrating bone marrow-derived cells Acta Neuropathologica Kevin Kemp, Johan Verhagen et al. 15
5 Reduced neuroprotective potential of the mesenchymal stromal cell secretome with ex vivo expansion, age and progressive multiple sclerosis Cytotherapy Juliana Redondo, Kevin Kemp et al. 29
6 Oxidative injury in multiple sclerosis cerebellar grey matter Brain Research Kevin Kemp, Juliana Redondo et al. 22
7 Cell fusion in the brain: two cells forward, one cell back Acta Neuropathologica Kevin Kemp, Alastair Wilkins et al. 28
8 Increased microglial catalase activity in multiple sclerosis grey matter Brain Research Elizabeth Gray, Kevin Kemp et al. 21
9 The Platform Protein Is Essential for Type IV Pilus Biogenesis Journal of Biological Chemistry Kevin Kemp, Melissa Kim et al. 84
10 Human Mesenchymal Stem Cells Increase Anti-oxidant Defences in Cells Derived from Patients with Friedreich’s Ataxia The Cerebellum Kevin Kemp, Elizabeth Gray et al. 22
11 The PPAR-gamma agonist pioglitazone protects cortical neurons from inflammatory mediators via improvement in peroxisomal function Journal of Neuroinflammation Elizabeth Gray, Mark Ginty et al. 79
12 Changes in Expression of the Antioxidant Enzyme SOD3 Occur Upon Differentiation of Human Bone Marrow-Derived Mesenchymal Stem Cells In Vitro Stem Cells and Development Helen Nightingale, Kevin Kemp et al. 31
13 Peroxisome proliferator-activated receptor-α agonists protect cortical neurons from inflammatory mediators and improve peroxisomal function European Journal of Neuroscience Elizabeth Gray, Mark Ginty et al. 31
14 Inflammatory Cytokine Induced Regulation of Superoxide Dismutase 3 Expression by Human Mesenchymal Stem Cells Stem Cell Reviews and Reports Kevin Kemp, Elizabeth Gray et al. 62
15 Chemotherapy-induced mesenchymal stem cell damage in patients with hematological malignancy Annals of Hematology Kevin Kemp, Sarah Wexler et al. 48
16 Fusion between human mesenchymal stem cells and rodent cerebellar Purkinje cells Neuropathology and Applied Neurobiology Kevin Kemp, David J. Gordon et al. 60
17 Mesenchymal stem cell‐secreted superoxide dismutase promotes cerebellar neuronal survival Journal of Neurochemistry Kevin Kemp, Kelly Hares et al. 98
18 Human bone marrow-derived mesenchymal stem cells secrete brain-derived neurotrophic factor which promotes neuronal survival in vitro Stem Cell Research Alastair Wilkins, Kevin Kemp et al. 225
19 EUV lithography Comptes Rendus Physique Kevin Kemp, Stefan Wurm 49
20 ICP-MS, INAA and PIXE analysis of airborne dust samples E.H. Larsen, Asger B. Hansen et al. 2

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Fernando Carceller Breakdown of academic impact, for papers by Yongchao Ma Breakdown of academic impact, for papers by Elisabet Lindqvist Breakdown of academic impact, for papers by Xuelian He Breakdown of academic impact, for papers by Suh Young Jeong Breakdown of academic impact, for papers by Astrid Jeibmann Breakdown of academic impact, for papers by Naoya Yamamoto Breakdown of academic impact, for papers by Pablo Martı́n-Vasallo Breakdown of academic impact, for papers by Ou Jin
Rankless by CCL
2026